Liqin Xiao

Wei Zhang^*,1, 

Xinjuan Lei^*,1, 

Xin Zhou^*,2,3, 

Boling He¹, 

Liqin Xiao¹, 

Huimin Yue¹, 

Shulin Wang¹, 

Yuting Sun¹, 

Yajun Wu¹, 

Liyang Wang^1,4, 

George Ghartey-Kwansah¹, 

Odell D. Jones⁵, 

Joseph L. Bryant⁶, 

MengMeng Xu⁷, 

Jianjie Ma³, 

Xuehon Xu¹ 

¹National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest of China/CGDB, Shaanxi Normal University College of Life Sciences, 

²Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Shaanxi Key Laboratory of Brain disorders, Institute of Basic & Translational Medicine, Xi'an Medical University, 

³, Ohio State University College of Medicine, 

⁴Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 

⁵, University of Pennsylvania ULAR, 

⁶, University of Maryland School of Medicine, 

⁷, Columbia University Medical Center